Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cutaneous T-Cell Lymphoma

fluorodeoxyglucose f18 has been researched along with Cutaneous T-Cell Lymphoma in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (46.67)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Kan, Y; Lu, X; Wang, W; Yang, J1
Imataki, O; Kadowaki, N; Uchida, S; Uemura, M; Yokokura, S1
Collins, GP; Corcoran, JP; Davies, SJ; Ho, LP; Moore, AJ1
Cascavilla, A; Legnani, G; Magistrelli, E; Manfredi, R; Sabbatani, S1
Alavi, A; Fardin, S; Gholami, S; Rook, AH; Samimi, S1
Fujiwara, H; Matsue, K; Sandoh, E1
Dai, W; Feng, X; Guan, Y; Hua, F; Zhao, J1
Berger, F; Pfluger, T; Reiser, MF; Schramm, N1
Jeong, HJ; Jeong, YJ; Kim, DW; Kim, JS; Kwak, JY; Lim, ST; Sohn, MH; Yim, CY1
Alavi, A; Fried, RG; Junkins-Hopkins, JM; Rook, AH; Saidman, BH; Schulman, N; Shapiro, M; Vittorio, CC; Yun, M1
Agress, H; Felig, DM; Sedarat, A; Waintraub, SE1
Becherer, A; Der-Petrossian, M; Hoffmann, M; Raderer, M; Trautinger, F; Valencak, J1
Alavi, A; Kumar, R; Xiu, Y; Zhuang, HM1
Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A1
Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KH; Olsasky, SM; Paknikar, S; Quigley, JM; Schmitz, J; Stemm, RA1

Other Studies

15 other study(ies) available for fluorodeoxyglucose f18 and Cutaneous T-Cell Lymphoma

ArticleYear
Primary Cutaneous Natural Killer/T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Demonstrated by 18F-FDG PET/CT.
    Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7

    Topics: Bone Marrow Transplantation; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Young Adult

2021
Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:2

    Topics: Adult; Aminopterin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Treatment Outcome

2019
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
    British journal of hospital medicine (London, England : 2005), 2014, Volume: 75, Issue:11

    Topics: Aged; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2014
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection.
    European journal of epidemiology, 2015, Volume: 30, Issue:5

    Topics: Carcinoma, Papillary; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Radionuclide Imaging; Syphilis; Thyroid Neoplasms; Thyroidectomy; Viral Load

2015
Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment.
    JAMA dermatology, 2016, Volume: 152, Issue:1

    Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms

2016
(18)F-Fluorodeoxyglucose positron emission tomography in primary cutaneous NK/T cell lymphoma, nasal type.
    European journal of haematology, 2009, Volume: 82, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Nose Neoplasms; Positron-Emission Tomography; Radiography

2009
F-18 FDG PET/CT in granulomatous slack skin.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:2

    Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed

2010
Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.
    The British journal of radiology, 2010, Volume: 83, Issue:989

    Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Panniculitis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subcutaneous Tissue; Thorax; Tomography, X-Ray Computed; Upper Extremity

2010
Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:10

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed

2010
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Neoplasm Staging; Radiopharmaceuticals; Skin Diseases; Tomography, Emission-Computed; Treatment Outcome

2002
Colonic adenomas detected by F-FDG PET.
    Gastrointestinal endoscopy, 2002, Volume: 56, Issue:5

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed

2002
Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas.
    Haematologica, 2004, Volume: 89, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Skin Neoplasms

2004
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    The British journal of dermatology, 2006, Volume: 155, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed

2006
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma.
    The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:10

    Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography

2006
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

2007